B-Cell Proliferation of Uncertain Malignant Potential

B-Cell Proliferation of Uncertain Malignant Potential — Trials · CancerIndex

Clinical trials

Registered studies

83 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Sponsor	Countries	Last update	Source
NCT02281279	Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma	withdrawn	Phase 1 / Phase 2	Mayo ClinicOTHER	0	Aug 11, 2016	clinicaltrials
NCT01652014	Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies	withdrawn	Phase 2	University of Medicine and Dentistry of New JerseyOTHER	1	Jul 14, 2016	clinicaltrials
NCT01769911	Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma	withdrawn	N/A	Fred Hutchinson Cancer CenterOTHER	1	May 7, 2015	clinicaltrials

Data updated 23 days agoSource updated Aug 11, 2016source: clinicaltrials